Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Reply to @clemg64: "Emerging Markets get lumped together, but they really are diverse areas with little in common. As a result, Asia is occasionally affected negatively by happenings in places like Turkey and Argentina that have nothing to do with the region. In the long run, however, fundamentals will win out, and Asia has strong fundamentals. Buy Matthews Asia funds."
I own MAPIX in my Roth too (kind of view it as an Asian VDIGX), and my fiancee owns MACSX in hers (Asian PRWCX). I'm quite happy with both and Matthews in general.
I suspect they're getting some flack because of performance over the past year or so. Certainly there is starting to be some negative feedback here. I just read this as an explanation of why, and a validation that with a long term horizon Asia is probably a good place to be and that there is value in regional rather than diversified products.
Comments
Thanks, Clem
BTW, I own MAPIX in a Roth.
I suspect they're getting some flack because of performance over the past year or so. Certainly there is starting to be some negative feedback here. I just read this as an explanation of why, and a validation that with a long term horizon Asia is probably a good place to be and that there is value in regional rather than diversified products.
But it's still a sales pitch.